450.88
price down icon0.68%   -2.4028
 
loading
Schlusskurs vom Vortag:
$453.28
Offen:
$450.31
24-Stunden-Volumen:
152.31K
Relative Volume:
0.21
Marktkapitalisierung:
$20.34B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$1.24B
KGV:
17.60
EPS:
25.6108
Netto-Cashflow:
$1.07B
1W Leistung:
+7.39%
1M Leistung:
+12.41%
6M Leistung:
+54.33%
1J Leistung:
+28.69%
1-Tages-Spanne:
Value
$449.51
$456.97
1-Wochen-Bereich:
Value
$419.21
$456.97
52-Wochen-Spanne:
Value
$266.98
$456.97

United Therapeutics Corp Stock (UTHR) Company Profile

Name
Firmenname
United Therapeutics Corp
Name
Telefon
(301) 608-9292
Name
Adresse
1000 SPRING ST, SILVER SPRING, MD
Name
Mitarbeiter
1,305
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
UTHR's Discussions on Twitter

Vergleichen Sie UTHR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
450.90 20.50B 3.08B 1.24B 1.07B 25.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.64 64.42B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.54 45.95B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
8.88 39.14B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.27 22.90B 16.70B -157.13M 1.19B -0.1446

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-26 Eingeleitet RBC Capital Mkts Outperform
2025-06-02 Eingeleitet Cantor Fitzgerald Overweight
2025-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2025-04-21 Hochstufung BofA Securities Underperform → Neutral
2024-07-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-02-12 Hochstufung Goldman Sell → Neutral
2024-02-05 Eingeleitet Leerink Partners Outperform
2023-12-08 Eingeleitet Wells Fargo Overweight
2022-12-06 Eingeleitet UBS Buy
2022-12-05 Eingeleitet Goldman Sell
2022-10-11 Eingeleitet Morgan Stanley Overweight
2022-09-20 Bestätigt BofA Securities Underperform
2022-09-19 Fortgesetzt Wedbush Outperform
2022-02-11 Eingeleitet BTIG Research Neutral
2021-07-14 Hochstufung Argus Hold → Buy
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-02-01 Hochstufung H.C. Wainwright Neutral → Buy
2020-09-14 Fortgesetzt JP Morgan Overweight
2020-06-25 Bestätigt H.C. Wainwright Neutral
2020-03-10 Hochstufung Jefferies Hold → Buy
2020-02-27 Hochstufung Cowen Market Perform → Outperform
2020-01-31 Hochstufung JP Morgan Neutral → Overweight
2019-12-03 Eingeleitet BofA/Merrill Underperform
2019-08-01 Hochstufung Jefferies Underperform → Hold
2019-08-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2019-07-01 Hochstufung Credit Suisse Neutral → Outperform
2019-05-17 Hochstufung UBS Sell → Neutral
2019-05-09 Hochstufung Credit Suisse Underperform → Neutral
2018-10-12 Hochstufung Standpoint Research Hold → Buy
2018-08-08 Herabstufung Credit Suisse Neutral → Underperform
2018-04-03 Hochstufung Credit Suisse Underperform → Neutral
2018-02-22 Bestätigt Barclays Underweight
2018-01-18 Fortgesetzt Credit Suisse Underperform
2017-12-27 Bestätigt Wedbush Outperform
2017-04-27 Bestätigt Wedbush Outperform
2017-03-30 Eingeleitet UBS Sell
2017-03-16 Eingeleitet Credit Suisse Underperform
Alle ansehen

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

pulisher
Oct 05, 2025

Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st

Oct 05, 2025
pulisher
Oct 03, 2025

How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada

Oct 02, 2025
pulisher
Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa

Oct 01, 2025
pulisher
Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

Is IPF the Next Big Market Opportunity for United Therapeutics? - Yahoo Finance

Oct 01, 2025
pulisher
Oct 01, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation - Investing.com India

Oct 01, 2025
pulisher
Sep 30, 2025

United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN

Sep 30, 2025
pulisher
Sep 29, 2025

United Therapeutics stock price target raised to $580 by UBS on Tyvaso outlook - Investing.com Australia

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments - Investing.com Australia

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics (UTHR): UBS Raises Price Target to $580, Mai - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments By Investing.com - Investing.com Australia

Sep 29, 2025
pulisher
Sep 29, 2025

Will United Therapeutics Corporation (UTH) stock beat international competitionWeekly Trade Review & Reliable Trade Execution Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data By Investing.com - Investing.com South Africa

Sep 29, 2025
pulisher
Sep 29, 2025

United Therapeutics Corporation $UTHR Holdings Lifted by State of Alaska Department of Revenue - MarketBeat

Sep 29, 2025
pulisher
Sep 28, 2025

Why United Therapeutics Corporation (UTH) stock stays undervaluedTrade Ideas & Verified Chart Pattern Trade Signals - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Analyzing drawdowns of United Therapeutics Corporation with statistical tools2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Winners & Losers & Low Risk Investment Opportunities - newser.com

Sep 28, 2025
pulisher
Sep 27, 2025

Chart based analysis of United Therapeutics Corporation trendsInsider Selling & Real-Time Stock Movement Alerts - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Augustine Asset Management Inc. Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Zai Lab (ZLAB) - The Globe and Mail

Sep 27, 2025
pulisher
Sep 26, 2025

United Therapeutics Rides Tyvaso Wins To Major Gains - Finimize

Sep 26, 2025
pulisher
Sep 26, 2025

RBC Capital initiates United Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada

Sep 26, 2025
pulisher
Sep 26, 2025

RBC Capital Initiates Coverage on United Therapeutics (UTHR) wit - GuruFocus

Sep 26, 2025
pulisher
Sep 26, 2025

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Sep 26, 2025
pulisher
Sep 26, 2025

Sowell Financial Services LLC Invests $333,000 in United Therapeutics Corporation $UTHR - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

RBC Capital initiates United Therapeutics stock with Outperform rating - Investing.com

Sep 26, 2025
pulisher
Sep 25, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock By Investing.com - Investing.com Nigeria

Sep 25, 2025
pulisher
Sep 25, 2025

Insider Sell: Christopher Causey Sells 1,000 Shares of United Th - GuruFocus

Sep 25, 2025
pulisher
Sep 25, 2025

Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock - Investing.com India

Sep 25, 2025
pulisher
Sep 25, 2025

United Therapeutics Corp. Hits New 52-Week High of $442.01 - Markets Mojo

Sep 25, 2025
pulisher
Sep 25, 2025

United Therapeutics Corporation $UTHR Shares Sold by Ruffer LLP - MarketBeat

Sep 25, 2025

Finanzdaten der United Therapeutics Corp-Aktie (UTHR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.27
price up icon 1.53%
$136.53
price down icon 1.93%
$54.79
price up icon 0.24%
$10.10
price down icon 0.25%
drug_manufacturers_specialty_generic RDY
$14.07
price down icon 0.05%
Kapitalisierung:     |  Volumen (24h):